Business & People
European Commission Initiative Improves Information for Patients on Biosimilar Medicines
EFPIA, Biosimilar Medicines Group and EuropaBio issued a press release regarding the European Commission unique Q&A for patients with reliable information on biosimilar medicines. It is stated that stakeholders value these efforts to provide unbiased, scientifically correct and yet easy to understand information on biosimilar medicines through the Q&A on Biosimilar Medicines, now available in 7 EU languages.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you